For the full year sales increased 4.0% to 23.7 billions, with a net profit of 9.57 billions. Total debt: 34.0 billions. The company product's innovation is very intense, currenty has 10 firt-in-human molecules in clinical development.
IMPORTANT:
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
Always make your analysis of your own before your trade.
If you find useful my analysis, please hit the LIKE button and follow me.
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
Always make your analysis of your own before your trade.
If you find useful my analysis, please hit the LIKE button and follow me.